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Abstract 
Chronic D-adrenergic receptor blockade is known to increase capillarization through elevated 
shear stress in rodents, but its effect on angiogenesis in humans is unknown.  Moreover, a higher 
capillary density is thought to be an important mechanism underlying the increase in skeletal 
muscle oxygen extraction following training, but this physiological effect has never been directly 
demonstrated.  
Purpose: To investigate the effect of increased basal shear stress on angiogenesis, and the role of 
enhanced skeletal muscle capillarisation on blood flow and oxygen extraction.  
Methods: Limb haemodynamics and oxygen extraction were measured at rest and during one-leg 
knee-extensor exercise (12 and 24W) in 10 healthy untrained young men before and after 4 weeks 
treatment with an Į1 receptor-antagonist (Terazosin, 1-2 mg day-1). Biopsies were taken from the m. 
vastus lateralis. 
Results: Resting leg blood flow was > 6 hours following Terazosin treatment (P<0.05). Basal 
capillary-to-fibre ratio was 1.68±0.07 and increased to 1.89±0.08 after treatment (P<0.05). Leg 
oxygen extraction during knee-extensor exercise was higher (4-5% ; P<0.05), leg blood flow and 
venous lactate levels lower (6-7%; P<0.05) and leg VO2 similar after Terazosin treatment.  
Conclusion: These results demonstrate that daily treatment with an D-adrenergic receptor blocker 
and a consequent increase in resting blood flow induces capillary growth in human skeletal muscle, 
likely due to increased shear stress. The increase in capillarisation led to enhanced O2 extraction in 
the exercising leg, concomitant with a lower blood flow and venous lactate levels. 
  
Introduction 
Angiogenesis is a complex process controlled by a number of pro- and anti-angiogenic factors, 
where the balance between these factors determines whether capillary growth or regression will 
occur (Egginton, 2009). Several physiological factors, of both mechanical and chemical origin, 
influence capillary growth in skeletal muscle by promoting the formation or release of a number 
angiogenic growth factors (Egginton, 2011).  Studies in rodents have shown that a period of 
chronically elevated blood flow induced by addition of the Į-adrenergic receptor blocker, prazosin, 
to drinking water leads to increased muscle capillarisation (Dawson & Hudlická, 1989; Ziada et al., 
1989; Zhou et al., 1998; Baum et al., 2004). The elevated basal blood flow in skeletal muscle leads 
to an increased frictional force by the blood on the capillary endothelium, which is registered by 
mechanosensors and transduced into endothelial cell activation and upregulation of angiogenic 
proteins (Milkiewicz et al., 2001; Egginton, 2011). In a previous study on human subjects, we 
showed that a period of increased blood flow and muscle stretch by passive movement of the lower 
leg induced angiogenesis in sedentary individuals (Hoier et al., 2010), however, the isolated effect 
of a chronic increase in resting blood flow has not been previously examined in humans.  
 
One of the most responsive angiogenic factors is endothelial nitric oxide synthase (eNOS), which 
can both be activated and increase in expression in response to elevated shear stress (Lamontagne et 
al., 1992; Baum et al., 2004; Williams et al., 2006a). eNOS has been shown to be important for 
shear stress-induced angiogenesis (Baum et al., 2004), an effect likely mediated in part by NO 
stimulation of vascular endothelial growth factor (VEGF) production (Tsurumi et al., 1997; Da 
Silva-Azevedo et al., 2002). VEGF is thought to be one of the most important growth factors 
regulating capillary supply in muscle (Wagner, 2011). Genetically modifie rodens without muscle-
specific VEGF have low levels of basal capillarisation in skeletal muscle, indicating a role for 
VEGF in regulation of developmental angiogenesis, but the animals also lack the ability to increase 
muscle capillarization  in response to exercise training (Olfert, 2010). The angiogenic effect of 
VEGF as well as its expression can be countered by the anti-angiogenic factor thrombospondin-1 
(TSP-1)(Olfert et al., 2006; Malek & Olfert, 2009). One of the underlying mechanisms may be the 
interference of eNOS signalling by TSP1 (Isenberg et al., 2009), and this anti-angiogenic factor 
may therefore also have important implications for shear stress-induced angiogenesis. 
 
Aerobic exercise training has marked effects on the cardiovascular system and skeletal muscle, 
enhancing systemic oxygen transport capacity as well as local oxidative capacity. One important 
adaptation is an increase in peripheral O2 extraction, and a consequent lowering of blood flow to the 
exercising limb when exercise is performed submaximally at the same workload (Kiens et al., 1993; 
Mortensen et al., 2012; Mortensen et al., 2014). This effect of training is thought to be, at least in 
part, attributed to a parallel increase in skeletal muscle capillarisation (Andersen & Henriksson, 
1977) which reduces O2 diffusion distance and mean erythrocyte transit time. The microvascular 
transport of oxygen to tissue is also influenced by the distribution and tortuosity of capillaries (Al-
Shammari et al., 2014). In addition, exercise training results in many other local adaptations, such 
as mitochondrial proliferation and optimised blood flow distribution pattern, which may also 
improve oxygen extraction efficiency (Hellsten & Nyberg, 2015). Due to the complex feedback 
regulation associated with metabolic demand during exercise, the isolated effect of an increase in 
capillarisation on O2 extraction and blood flow has not previously been examined.  
 
The aim of the present study was to investigate the effect of a chronic increase in resting blood flow 
and a consequent elevated vascular shear stress on skeletal muscle capillarisation, O2 extraction and 
blood flow in humans. The hypothesis was that an increase in vascular shear stress would induce an 
increase in skeletal muscle capillarisation through upregulation of pro-angiogenic factors. 
Moreover, we hypothesised that an increase in capillarisation would increase skeletal muscle O2 
extraction and consequently lower blood flow during exercise. To this end, we obtained muscle 
biopsies and measured resting and exercising haemodynamics and blood gasses before and after a 
four week period of WUHDWPHQWZLWKDQĮ-receptor antagonist to increase skeletal muscle blood flow 
in untrained individuals. 
 
Methods 
Ten young, untrained healthy males were studied (24±2 years, 71±3 kg and 180±2 cm). The study 
was approved by the Ethics Committee of the capitol region of Denmark, and conducted in 
accordance with the guidelines of the Declaration of Helsinki. Written informed consent was 
obtained from all individuals before enrollment into the study. Before the first experimental day the 
individuals visited the laboratory on two occasions to become accustomed to the one-leg knee-
extensor model and to perform an incremental bicycle ergometer exercise test in which pulmonary 
maximal oxygen uptake (VO2max) was determined with a metabolic cart (CPET system, Cosmed, 
Rome, Italy). 
 
Terazosin intervention 
Subjects received oral 7HUD]RVLQ Į1 antagonist; Sinalfa, Amdipharm, Dublin, Ireland), with an 
estimated half-life of 12 hours, for 4 weeks. During the first week, subjects ingested 1 mg every 
night before bed, and for the three subsequent weeks they ingested 2 mg each night. The subjects 
completed an experimental day before the intervention period and 3 days after the last Terazosin 
ingestion. In four subjects, resting leg blood flow was measured during the first six hours after 
Terazosin administration and in all subjects resting blood flow was assessed each week throughout 
the intervention period.  
 
Experimental days 
After local anaesthesia (lidocaine 20%), catheters were placed into the femoral artery and vein of 
the experimental leg, and a muscle biopsy was obtained from m. vastus lateralis using the 
Bergström-technique with suction. Following 30 min of supine rest, the subjects completed 5 min 
of passive leg movement (lower leg was strapped to the ergometer and was moved passively at a 
frequency of 60 r.p.m) followed by active one-legged knee-extensor exercise (5 min at 12 and 12 
W). Blood samples were drawn at rest (supine and seated in the knee extensor ergometer), during 
passive leg movement (at 0.5, 1.5 and 4 min) and during active exercise (at 2.5 and 4.5 min).  
 
Measurements 
Leg blood flow (LBF) was measured with ultrasound Doppler (Logic E9, GE Healthcare) equipped 
with a linear probe operating an imaging frequency of 9 MHz and Doppler frequency of 4.2-5.0 
MHz. The site of blood velocity measurements in the common femoral artery was distal to the 
inguinal ligament, but above the bifurcation into the superficial and profound femoral branch to 
avoid turbulence. All recordings were obtained at the lowest possible insonation angle, and always 
below 60°. The sample volume was maximized according to width of the vessel, and kept clear of 
the vessel walls. A low-velocity filter (velocities <1.8 m.s-1) rejected noise caused by turbulence at 
the vascular wall. Doppler tracings and B-mode images were recorded continuously, and Doppler 
tracings were averaged over 8 heart cycles at the time of blood sampling. Vessel diameter was 
determined after each Doppler recording. Arterial diameter was recorded during systole from 
arterial B-mode images with the vessel parallel to the transducer. Intra-arterial pressure was 
monitored with transducers (Pressure Monitoring Kit, Baxter) positioned at the level of the heart. 
Leg mass was calculated from whole-body dual-energy x-ray absorptiometry scanning (Prodigy, 
GE Healthcare). 
 
Analysis 
Blood samples 
Blood gases, haemoglobin, and lactate were measured using an ABL725 analyzer (Radiometer, 
Glostrup, Denmark). 
Immunohistochemistry 
Liquid N2-frozen biopsy VDPSOHVZHUHFXWXVLQJDFU\RVWDWLQWRȝPWKLFNWUDQVYHUVHVHFWLRQV, 
attached to coated slides, and fixed by immersion in acetone (-Û&IRUVHF) followed by 2% 
formaldehyde (2 min at room temperature). The sections were rinsed in 10 mM phosphate-buffered 
saline containing 1% bovine serum albumin (PBS±BSA) and blocked for 1 h with PBS±BSA. The 
lectin Ulex Europaeus agglutinin-1 (UEA-1) was used as endothelial cell marker (DAKO A/S, 
Glostrup, Denmark). The distribution of muscle fibers containing MHC I or MHC IIa was 
determined with the use of the antibodies MHCI (M8421, Sigma, St Louis, Missouri, USA) and 
anti-human MHC II (N2.261, Developmental Studies Hybridoma Bank, University of Iowa). The 
sections were incubated with biotinylated secondary antibody (DAKO A/S), with binding visualized 
using an ABComplex kit with alkaline phosphatase (ABComplex/AP, DAKO A/S).  
 
Capillaries and muscle fibers were visualised at a total magnification of x 400. On average 300 
fibers were counted per biopsy. Morphometric data were calculated using digitised images and the 
image analysis software ImageJ (NIH). The number of capillaries per fiber (C:F), the fiber cross-
sectional area (FCSA, µm2), and capillary density (CD, mm-2) were computed from all biopsies 
with adequate muscle preservation.  
Using samples from a subset of 5 individuals, binary images were then imported into an analysis 
package to estimate capillary distribution (Al-Shammari et al., 2014). A region of interest (ROI) 
was placed over the images to allow unbiased sampling to calculate C:F and CD (Egginton, 1990), 
and used to quantify the area of tissue supplied by a single capillary (capillary domain) based on the 
tessellation of Voronoi polygons representing that area of tissue closer to one capillary than another. 
The domain areas were normalised by logarithmic transformation to form a parametric data series 
and the SD calculated. This area-based approach permits calculation of the local heterogeneity in 
capillary spacing (logSD). 
  
Western blot 
Biopsies were freeze-dried and dissected free from fat, blood and connective tissue. The biopsy was 
homogenized in homogenization buffer (10% glycerol, 20 mM sodium pyrophosphate, 150 mM 
NaCl, 50 mM HEPES, 1% NP-40, 20 mM ȕ-glycerophosphate, 2 mM Na3VO4, 10 mM NaF, 2 mM 
PMSF, 1 mM EDTA and EGTA, aprotinine, leupeptine and benzamidine) while kept on ice at all 
times. The protein concentration of lysate samples was determined by a BSA protein assay (Pierce, 
Rockford, IL, USA). Lysate proteins were separated using SDS gels (Bio-Rad Laboratories) and 
transferred (semidry) to PVDF membranes (Immobilion Transfer Membrane, Millipore).  The 
membranes were incubated with primary antibodies to VEGF (A-20, Santa Cruz Biotechnology, 
Santa Cruz), FLK-1 (sc19530, Santa Cruz Biotechnology), eNOS (610297 BD Transduction 
Laboratories), TSP-1 (ab85762, Abcam, USA). Secondary antibody horseradish-peroxidase-
conjugated goat anti-rabbit (P-0448, Dako, Glostrup, Denmark) was used for detection of the 
proteins. Subsequent to exposure (Kodak Image Station, 2000MM) and quantification (Kodak 
Molecular Imaging software), the protein content was expressed in arbitrary units related to human 
standards. 
 
Statistical analysis  
A two-way repeated measures ANOVA was performed to detect treatment-induced changes. After a 
significant F-test, pairwise differences were identified using Tukey posthoc procedure. The 
significance level was set at P<0.05 and data expressed as means ±SEM. Steady state conditions 
were reached after the first 0.5 min of passive leg movement and means were obtained at 0.5, 1.5 
and 4 min. No statistical difference was seen between measurements obtained at 2.5 and 4.5 min 
during active exercise, and data presented are therefore the mean of these measurements.  
 
Results 
Blood flow 
Acute terazosin administration increased femoral arterial resting blood flow by 23±22, 39±7 and 
40±5 % after 2, 4 and 6 hours, respectively. During chronic Terazosin treatment, resting femoral 
arterial blood flow was increased from 195±23 ml.min-1 to 301±41 ml.min-1 (2 weeks) and 271±33 
ml.min-1 (4 weeks) (both P<0.05 vs. baseline). 
 
Skeletal muscle morphology 
Global analysis of capillary to fiber ratio (C:F) (1.69±0.08 vs. 1.90±0.08 with Terazosin) and 
capillary density (335±17 vs. 416±60 capillaries mm2-1with Terazosin) were higher after Terazosin 
treatment (P<0.05; Figure 1). Similar values were obtained from the samples used for higher 
resolution analysis (C:F: 1.52±0.06 vs. 1.78±0.08 with Terazosin (n=5; P<0.05)), confirming a 
representative subset. Here, capillary domain area was similar in both samples (1740±63 vs. 
1883±69 µm2) as was ICD (46.1±0.9 vs. 47.6±0.9 µm). Importantly, the quantitative measure of 
capillary homogeneity, logSD, was unchanged (0.155 vs. 0.145 µm) (Figure 2). 
 
Performance 
There were no differences in VO2max (3.5±0.1 vs. 3.3±0.1 l min-1 with Terazosin) or peak 
workload (297±11 vs. 300±11 W with Terazosin) obtained during incremental cycling and knee-
extensions (57±3 vs. 60±3 W with Terazosin) before and after Terazosin treatment (Figure 3). 
 
Haemodynamics 
Seated resting leg blood flow and vascular conductance were lower after Terazosin treatment 
(P<0.05), whereas arterial blood pressure was unchanged (Figure 4). Terazosin treatment did not 
alter hemodynamics during passive leg movement. After Terazosin treatment, leg O2 extraction 
during exercise at 12 and 24 watts was higher (P<0.05), leg blood flow and vascular conductance 
were lower (P<0.05), leg VO2 similar, and femoral venous lactate levels lower (Figure 5; P<0.05).  
 
Protein content of angiogenic and angiostatic factors in skeletal muscle  
There were no differences in VEGF, FLK, TSP-1 or eNOS protein content before and after 
Terazosin treatment (Figure 6). 
 
Discussion 
The aim of the present study was to determine the effect of an increase in vascular shear stress on 
angiogenesis, O2 extraction and blood flow in skeletal muscle. The results show that an elevated 
resting blood flow accomplished by a four week period of D1-adrenergic blockade increases 
skeletal muscle capillarisation in humans. Moreover, for the first time we demonstrate that the 
functional consequences of an increase in skeletal muscle capillarisation without other concomitant 
aerobic adaptations are an increase in O2 extraction, a lower blood flow to the exercising limb, and 
lower venous lactate levels. 
 
We show that four week treatment with an Į1-adrenoreceptor antagonist results in a chronic 
elevation in resting limb blood flow and an increase in skeletal muscle capillarisation. The increase 
in femoral artery perfusion is of similar magnitude to that previously reported during acute 
adrenergic antagonism in hypertensive men (Scarpelli et al., 1981). Importantly, capillary growth 
GXULQJ Į1-adrenoreceptor blockade only appears to occur in tissues with elevated blood flow, 
suggesting that capillary shear stress is indeed the underlying mechanism of the increase in skeletal 
muscle capillarization (Ziada et al., 1989). This angiogenic response appears to be independent of 
the vasodilator used to elevate shear stress (Egginton et al., 2016). In a previous study, we 
examined the effect of four weeks regular passive leg movement on muscle capillarisation and 
found a small, but significant increase in capillary supply (Hoier et al., 2010). Passive leg 
movement induces an approximate 2-3 fold increase in blood flow and a 20% passive stretch of the 
muscle (Hellsten et al., 2008), thus the effect of shear stress versus stretch on angiogenesis could 
not be distinguished in this model. The current findings of increased capillarisation with increased 
resting blood flow suggest that chronic elevation of shear stress is a sufficiently potent stimulus to 
promote capillary growth. A comparison between these studies would also indicate that low level 
more long term  (>8 hours) as opposed to a higher level, but temporary (90 min) increase in shear 
stress may be more effective in inducing angiogenesis, which may have important implications for 
translation of these findings into clinical angiotherapy.  
 
The quantitative measure of homogeneity in capillary distribution, logSD, represents the degree of 
variability amongst capillary domains e.g. a decrease would show a more regular pattern of 
capillary distribution. Canonical sprouting angiogenesis is likely responsive to the local metabolic 
environment and as such is expected to produce a more homogeneous distribution of capillaries, 
whereas the lack of a myocyte response to hyperaemia would suggest a more stochastic angiogenic 
response, expected to result in an increased capillary supply of similar spatial distribution. The 
logSD values are consistent with this expectation, adding further support to the concept of direct 
endothelial cell mechanotransduction of elevated shear stress (Olfert et al., 2016). 
 
It is known that a period of exercise training can increase oxygen extraction and lower blood flow 
in the muscle during submaximal exercise (Kiens et al., 1993; Mortensen et al., 2012; Mortensen et 
al., 2014). As increased skeletal muscle capillarisation and increased muscle oxidative capacity are 
common adaptations to aerobic exercise training, it has been assumed that the increased oxygen 
extraction has been a result of these adaptations. However, no in vivo study in either animals or 
humans has directly demonstrated the effect of increased capillarisation on muscle oxygen 
extraction and blood flow. In the present study, O2 extraction in the exercising leg was increased in 
parallel with an increase in capillarisation. Since the Terazosin treatment was followed by a 3 day 
wash out period before the experimental day, this effect was not related to the acute effects of the 
vasodilator. Increased capillary density improves local O2 delivery by lowering the diffusion 
distance from capillary to skeletal muscle fibre, and increasing the mean capillary transit time of 
erythrocytes (Krogh & Lindhard, 1913). Although leg VO2 was not significantly different before 
and after the Terazosin treatment, improved O2 diffusivity and consequently improved support for 
aerobic metabolism likely explain the lower femoral venous lactate levels following exercise after 
treatment. The increased O2 extraction and lower blood flow during exercise is similar to the 
changes observed after a period of aerobic exercise training, supporting the concept that increased 
capillarisation and subsequent improved O2 diffusion is a major driver for increased O2 extraction in 
the trained state. Although this has commonly been assumed, to date no studies have directly 
demonstrated this effect of capillarisation in muscle. 
 
Despite the improved conditions for O2 diffusion, we did not observe an increase in maximal O2 
uptake or peak workload during cycling or peak workload during knee-extensions. The lack of 
effect of an increased capillary supply on maximal O2 uptake is consistent with the concept that 
capacity of the systemic circulation to deliver O2 to exercising muscles is the major factor limiting 
maximal O2 uptake (Andersen & Saltin, 1985; Mortensen et al., 2005). The lack of effect during 
knee-extensions may suggest that mitochondrial oxidative capacity rather than diffusion capacity is 
the rate limiting step during small-muscle mass exercise (Blomstrand et al., 1997), although we did 
not determine leg VO2 during maximal knee-extensions to verify this. 
 
The mechanism(s) by which an increase in capillary shear stress induces angiogenesis has been 
suggested to be linked to an increase in eNOS and NO formation (Baum et al., 2004), and NO is 
known to influence VEGF expression (Tsurumi et al., 1997; Da Silva-Azevedo et al., 2002). 
Despite the increase in resting blood flow and capillarisation, there were no changes in protein 
levels of eNOS, VEGF, VEGF receptor 2 or TSP-1 following the intervention period. With the 
exception of eNOS these observations are in agreement with most reports in humans that these 
proteins are not altered with training or passive movement (Høier et al., 2012; Høier & Walker, 
2013). In contrast, levels of eNOS are generally enhanced with aerobic training (Hellsten & 
Nyberg, 2015), and both acute and repeated passive movement increases expression of eNOS 
mRNA (Hellsten et al., 2008; Hoier et al., 2010). The response of angiogenic factors in rodent 
skeletal muscle differ somewhat from what is generally found in humans in that levels of VEGF, 
VEGF receptor 2, TSP-1 in mice and rats appear to be more readily altered by a period of stimuli 
such as muscle contraction, shear stress or passive stretch (Williams et al., 2006b; Olenich et al., 
2013). This may be linked to the greater stimulus intensity leading to a more rapid angiogenic 
response in rodents. A possible explanation for the lack of effect on eNOS and VEGF expression 
following Terazosin treatment is that the muscle biopsies were obtained 3 days after treatment 
ended.  
 
In conclusion, increased resting blood flow leading to enhanced capillary shear stress induces 
angiogenesis in human skeletal muscle. Moreover, an increase in skeletal muscle capillarisation 
increases O2 extraction and lowers blood flow, and appears to lower anaerobic metabolism at the 
same exercise workload. Increasing capillarisation could therefore be an important treatment for 
patients with microvascular dysfunction in skeletal muscle to improve metabolic efficiency.  
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Table 1 
 
 
Before 
 
After 
 
Rest 
 
Exercise 
 
Rest 
 
Exercise 
 
Supine Seated   Passive 12 W 24W   Supine Seated   Passive 12 W 
Hemoglobin (g l-1) 
      
 
    FA 13.9±0.4 14.1±0.4 
 
14.2±0.3 14.5±0.3 14.4±0.3 
 
13.5±0.2 14.0±0.3 
 
14.0±0.3 14.4±0.3 
FV 13.7±0.5 13.7±0.5 
 
14.1±0.4 14.5±0.5 14.5±0.5 
 
13.2±0.2 13.8±0.3 
 
13.8±0.3 14.2±0.2 
PO2 (mmHg) 
      
 
    FA 97±5 97±2 
 
106±5 102±3 105±2 
 
101±1 99±1 
 
100±3 103±3 
FV 37±2 29±2 
 
35±2 26±1 26±1 
 
33±2 25±1* 
 
31±2 24±1* 
O2 Saturation (%) 
      
 
    FA 97.6±0.4 97.4±0.4 
 
97.6±0.3 97.7±0.4 98.0±0.2 
 
97.6±0.4 97.5±0.3 
 
97.6±0.3 97.8±0.3 
FV 66.4±4.1 50.3±4.5 
 
62.2±4.5 41.3±1.8 37.7±2.5 
 
61.6±3.5 43.2±2.1* 
 
57.3±3.4 36.4±1.5* 
O2 content (ml l-1) 
      
 
    FA 184±6 187±5 
 
189±4 193±5 192±4 
 
180±3 185±4 
 
186±4 192±3 
FV 123±10 94±10 
 
116±14 81±5 69±8 
 
111±8 81±4* 
 
108±8 70±3* 
 
 
 
  
Figure legends 
Figure 1. Capillaries per muscle fiber (A) and capillary density (B) in skeletal muscle  
(m. vastus lateralis) before and after four weeks of WUHDWPHQWZLWKDQĮ1-receptor blocker to  
increase vessel wall shear stress. * different compared to before treatment, P<0.05  
 
Figure 2. Frequency distribution of capillary domain areas following five weeks Terazosin 
supplementation showing similar, log-normal distribution patterns, despite an increase in capillary 
supply. 
 
Figure 3. Maximal oxygen uptake (A), maximal workoad during maximal cycling (B) and  
maximal workoad during maximal knee-extension before and after four weeks of treatment  
with adrenoreceptor blockage to increase vascular shear stress.  
 
Figure 4. Leg blood flow, mean arterial pressure and leg vascular conductance during  
resting conditions, passive leg movement and knee-extension before and after four weeks  
of Terazosin treatment. * different compared to baseline, P<0.05  
 
Figure 5. Leg a-vO2 difference, leg VO2 and femoral venous lactate under resting conditions, 
passive leg movement and knee-extension before and after four weeks treatment. *P<0.05 vs. 
baseline. 
 
Figure 6. Protein levels for pro-angiogenic and angiostatic factors in skeletal muscle  
before and after four weeks Terazosin treatment. a) Vascular endothelial growth factor (VEGF), b) 
VEGF receptor 2 (Flk-1), c), thrombospondin-1 (TSP-1), d) endothelial nitric oxide synthase. 
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Figure 4. 
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Figure 5. 
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Figure 6.  
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